Mainz Biomed B.V.(MYNZ),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

MYNZ Mainz Biomed B.V.

Market Closed 05-03 16:00:00 EDT

0.7367

-0.0284

-3.71%

盘后0.7367

+0.00000.00%

16:53 EDT

High0.7950	Low0.7200	Vol169.56K
Open0.7909	D1 Closing0.7651	Amplitude9.80%
Mkt Cap16.12M	Tradable Cap13.55M	Total Shares21.89M
T/O125.64K	T/O Rate0.92%	Tradable Shares18.39M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

{"stockData":{"symbol":"MYNZ","market":"US","secType":"STK","nameCN":"Mainz Biomed B.V.","latestPrice":0.7367,"timestamp":1714766400000,"preClose":0.765101,"halted":0,"volume":169564,"hourTrading":{"tag":"盘后","latestPrice":0.7367,"preClose":0.7367,"latestTime":"16:53 EDT","volume":2,"amount":1.51,"timestamp":1714769598689},"delay":0,"floatShares":18389181,"shares":21886575,"eps":-1.618962,"marketStatus":"Market Closed","change":-0.028401,"latestTime":"05-03 16:00:00 EDT","open":0.7909,"high":0.795,"low":0.72,"amount":125643.10880999999,"amplitude":0.098026,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-1.618962,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Market Trading","tradingStatus":1,"beginTime":1714982400000},"marketStatusCode":7,"adr":0,"listingDate":1635998400000,"exchange":"NASDAQ","adjPreClose":0.765101,"postHourTrading":{"tag":"盘后","latestPrice":0.7367,"preClose":0.7367,"latestTime":"16:53 EDT","volume":2,"amount":1.51,"timestamp":1714769598689},"volumeRatio":0.8175092109449198},"requestUrl":"/m/hq/s/MYNZ","defaultTab":"news","newsList":[{"id":"2431897542","title":"mRNA Is Promising A Breakthrough In Fighting Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2431897542","media":"Benzinga","top":-1,"share":"https://ttm.financial/m/news/2431897542?lang=en_us&edition=fundamental","pubTime":"2024-04-30 00:02","pubTimestamp":1714406563,"startTime":"0","endTime":"0","summary":"Mainz Biomed N.V. to revolutionize colorectal cancerdiagnostics and prevention.CRC has been recognized as the second most lethal cancer both in the U.S. and Europe. However, it is also among the most preventable ones as early detection results insurvival rates above 90%.A company specialized in molecular genetics diagnostic, Mainz Biomed,whoseflagship product, ColoAlert, a CRC screening test already showed its ability to detect even pre-cancerous polyps known as advanced adenomas thanks to mRNA biomarkers,just announced significant findings from a pooled clinical study as its flagship project undergoes a pivotal FDA clinical study for U.S. regulatory approval.Mainz Biomedconducted this study to fine tune and evaluate novel mRNA biomarkersalong withproprietary AI algorithm for integration into pivotal FDA PMA clinical trial for its next-generation CRC screening tool.With the help of mRNA, promising new treatments have emerged.Since its beginnings, Moderna has leveraged the power of mach","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/STtqdx4fS_ngXH.X1tRm7w--~B/aD02NzU7dz0xMjAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/Benzinga/b1db3fde5bb654dd2ee59b99c89419f0","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/STtqdx4fS_ngXH.X1tRm7w--~B/aD02NzU7dz0xMjAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/Benzinga/b1db3fde5bb654dd2ee59b99c89419f0"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/mrna-promising-breakthrough-fighting-cancer-160243290.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2430285339","title":"Mainz Biomed Reports Positive Topline Results from Pooled Study Evaluating Novel mRNA Biomarkers and Proprietary AI Algorithm for Integration into Pivotal FDA PMA Clinical Trial for Next Generation Colorectal Cancer Diagnostic","url":"https://stock-news.laohu8.com/highlight/detail?id=2430285339","media":"GlobeNewswire","top":-1,"share":"https://ttm.financial/m/news/2430285339?lang=en_us&edition=fundamental","pubTime":"2024-04-25 13:29","pubTimestamp":1714022940,"startTime":"0","endTime":"0","summary":"Groundbreaking topline results demonstrated sensitivity for colorectal cancer of 92% with specificity of 90% and best-in-class sensitivity for advanced adenoma of 82%690 subjects analyzed including pr","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2024/04/25/2869737/0/en/Mainz-Biomed-Reports-Positive-Topline-Results-from-Pooled-Study-Evaluating-Novel-mRNA-Biomarkers-and-Proprietary-AI-Algorithm-for-Integration-into-Pivotal-FDA-PMA-Clinical-Trial-fo.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2429395774","title":"Mainz Biomed Announces Upcoming Annual Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2429395774","media":"TIPRANKS","top":-1,"share":"https://ttm.financial/m/news/2429395774?lang=en_us&edition=fundamental","pubTime":"2024-04-24 18:59","pubTimestamp":1713956344,"startTime":"0","endTime":"0","summary":"Mainz Biomed B.V. (MYNZ) has released an update. Mainz Biomed N.V. has scheduled its annual general meeting for shareholders on May 31, 2024, at 14...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/mainz-biomed-announces-upcoming-annual-meeting?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/mainz-biomed-announces-upcoming-annual-meeting?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"gpt_icon":0},{"id":"2428658236","title":"Mainz Biomed Secures New Funding Agreement","url":"https://stock-news.laohu8.com/highlight/detail?id=2428658236","media":"TIPRANKS","top":-1,"share":"https://ttm.financial/m/news/2428658236?lang=en_us&edition=fundamental","pubTime":"2024-04-19 19:29","pubTimestamp":1713526173,"startTime":"0","endTime":"0","summary":"Mainz Biomed B.V. (MYNZ) has released an update. Mainz Biomed B.V. enters into a supplemental agreement with YA II PN, LTD., involving a third Pre-...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/mainz-biomed-secures-new-funding-agreement?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/mainz-biomed-secures-new-funding-agreement?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"gpt_icon":0},{"id":"2426435518","title":"Mainz Biomed B.V. Confronts Escalating Cybersecurity Dangers Threatening Operations and Data Security","url":"https://stock-news.laohu8.com/highlight/detail?id=2426435518","media":"TIPRANKS","top":-1,"share":"https://ttm.financial/m/news/2426435518?lang=en_us&edition=fundamental","pubTime":"2024-04-10 14:00","pubTimestamp":1712728850,"startTime":"0","endTime":"0","summary":"Mainz Biomed B.V. (MYNZ) has disclosed a new risk, in the Cyber Security category. Mainz Biomed B.V. faces significant cybersecurity threats that c...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/mainz-biomed-b-v-confronts-escalating-cybersecurity-dangers-threatening-operations-and-data-security?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/mainz-biomed-b-v-confronts-escalating-cybersecurity-dangers-threatening-operations-and-data-security?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"gpt_icon":0},{"id":"2417219757","title":"Analysts Are Bullish on Top Healthcare Stocks: Iterum Therapeutics (ITRM), Mainz Biomed B.V. (MYNZ)","url":"https://stock-news.laohu8.com/highlight/detail?id=2417219757","media":"TIPRANKS","top":-1,"share":"https://ttm.financial/m/news/2417219757?lang=en_us&edition=fundamental","pubTime":"2024-03-07 00:30","pubTimestamp":1709742650,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Iterum Therapeutics (ITRM – Research Report) and Mai...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-top-healthcare-stocks-iterum-therapeutics-itrm-mainz-biomed-b-v-mynz?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-top-healthcare-stocks-iterum-therapeutics-itrm-mainz-biomed-b-v-mynz?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"gpt_icon":0},{"id":"2409274259","title":"2024 Promises To Bring Pharmaceutical Breakthroughs On The Oncology Front","url":"https://stock-news.laohu8.com/highlight/detail?id=2409274259","media":"Benzinga","top":-1,"share":"https://ttm.financial/m/news/2409274259?lang=en_us&edition=fundamental","pubTime":"2024-02-08 01:13","pubTimestamp":1707325988,"startTime":"0","endTime":"0","summary":"Revolutionizing treatment for melanoma, and possibly lung cancer.Revolutionizing colorectal cancer screening and increasing the success of treatment.","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/2j1z3i7PywZTYK__GYbA0w--~B/aD02NzU7dz0xMjAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/Benzinga/6957f9c8a68894b1758838862f34eb15","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/2j1z3i7PywZTYK__GYbA0w--~B/aD02NzU7dz0xMjAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/Benzinga/6957f9c8a68894b1758838862f34eb15"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/2024-promises-bring-pharmaceutical-breakthroughs-171308301.html","is_publish_highlight":false,"gpt_icon":0}],"profile":{"websiteUrl":"http://mainzbiomed.com","stockEarnings":[{"period":"1week","weight":-0.0995},{"period":"1month","weight":-0.3179},{"period":"3month","weight":-0.1581},{"period":"6month","weight":-0.7005},{"period":"1year","weight":-0.8487},{"period":"ytd","weight":-0.3649}],"compareEarnings":[{"period":"1week","weight":0.006},{"period":"1month","weight":-0.0156},{"period":"3month","weight":0.0343},{"period":"6month","weight":0.1762},{"period":"1year","weight":0.262},{"period":"ytd","weight":0.0757}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Mainz Biomed N.V., a molecular genetics cancer diagnostic company, develops in-vitro diagnostic (IVD) and research use only tests for clinical diagnostics. It offers ColoAlert, a colorectal cancer screening stool-based deoxyribonucleic acid test; and PancAlert, a product candidate for a pancreatic cancer screening test. The company has a research collaboration with Microba Life Sciences to discover and develop novel therapeutics for major diseases. The company was founded in 2008 and is based in Mainz, Germany.","exchange":"NASDAQ","name":"Mainz Biomed B.V.","nameEN":"Mainz Biomed B.V."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Mainz Biomed B.V.(MYNZ),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Mainz Biomed B.V.(MYNZ) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Mainz Biomed B.V.,MYNZ,Mainz Biomed B.V.股票,Mainz Biomed B.V.股票老虎,Mainz Biomed B.V.股票老虎国际,Mainz Biomed B.V.行情,Mainz Biomed B.V.股票行情,Mainz Biomed B.V.股价,Mainz Biomed B.V.股市,Mainz Biomed B.V.股票价格,Mainz Biomed B.V.股票交易,Mainz Biomed B.V.股票购买,Mainz Biomed B.V.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Mainz Biomed B.V.(MYNZ),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Mainz Biomed B.V.(MYNZ) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction